1 Study Coverage
1.1 Gemigliptin Product Introduction
1.2 Global Gemigliptin Outlook 2021 VS 2025 VS 2031
1.2.1 Global Gemigliptin Sales in US$ Million for the Year 2025-2031
1.2.2 Global Gemigliptin Sales in Volume for the Year 2025-2031
1.3 United States Gemigliptin Outlook 2021 VS 2025 VS 2031
1.3.1 United States Gemigliptin Sales in US$ Million for the Year 2025-2031
1.3.2 United States Gemigliptin Sales in Volume for the Year 2025-2031
1.4 Gemigliptin Market Size, United States VS Global, 2021 VS 2025 VS 2031
1.4.1 The Market Share of United States Gemigliptin in Global, 2021 VS 2025 VS 2031
1.4.2 The Growth Rate of Gemigliptin Market Size, United States VS Global, 2021 VS 2025 VS 2031
1.5 Gemigliptin Market Dynamics
1.5.1 Gemigliptin Industry Trends
1.5.2 Gemigliptin Market Drivers
1.5.3 Gemigliptin Market Challenges
1.5.4 Gemigliptin Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Gemigliptin Market Segment by Type
2.1.1 For Type 2 Diabetes
2.1.2 Others
2.2 Global Gemigliptin Market Size by Type
2.2.1 Global Gemigliptin Sales in Value, by Type (2021, 2025 & 2031)
2.2.2 Global Gemigliptin Sales in Volume, by Type (2021, 2025 & 2031)
2.2.3 Global Gemigliptin Average Selling Price (ASP) by Type (2021, 2025 & 2031)
2.3 United States Gemigliptin Market Size by Type
2.3.1 United States Gemigliptin Sales in Value, by Type (2021, 2025 & 2031)
2.3.2 United States Gemigliptin Sales in Volume, by Type (2021, 2025 & 2031)
2.3.3 United States Gemigliptin Average Selling Price (ASP) by Type (2021, 2025 & 2031)
3 Market by Application
3.1 Gemigliptin Market Segment by Application
3.1.1 Clinical Use
3.1.2 Hospital Use
3.2 Global Gemigliptin Market Size by Application
3.2.1 Global Gemigliptin Sales in Value, by Application (2021, 2025 & 2031)
3.2.2 Global Gemigliptin Sales in Volume, by Application (2021, 2025 & 2031)
3.3.3 Global Gemigliptin Average Selling Price (ASP) by Application (2021, 2025 & 2031)
3.3 United States Gemigliptin Market Size by Application
3.3.1 United States Gemigliptin Sales in Value, by Application (2021, 2025 & 2031)
3.3.2 United States Gemigliptin Sales in Volume, by Application (2021, 2025 & 2031)
3.3.3 United States Gemigliptin Average Selling Price (ASP) by Application (2021, 2025 & 2031)
4 Global Gemigliptin Competitor Landscape by Company
4.1 Global Gemigliptin Market Size by Company
4.1.1 Top Global Gemigliptin Manufacturers Ranked by Revenue (2025)
4.1.2 Global Gemigliptin Revenue by Manufacturer (2021-2025)
4.1.3 Global Gemigliptin Sales by Manufacturer (2021-2025)
4.1.4 Global Gemigliptin Price by Manufacturer (2021-2025)
4.2 Global Gemigliptin Concentration Ratio (CR)
4.2.1 Gemigliptin Market Concentration Ratio (CR) (2021-2025)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Gemigliptin in 2021
4.2.3 Global Gemigliptin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Gemigliptin Manufacturing Base Distribution, Product Type
4.3.1 Global Gemigliptin Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Gemigliptin Product Type
4.3.3 Date of International Manufacturers Enter into Gemigliptin Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Gemigliptin Market Size by Company
4.5.1 Top Gemigliptin Players in United States, Ranked by Revenue (2025)
4.5.2 United States Gemigliptin Revenue by Players (2023, 2024 & 2025)
4.5.3 United States Gemigliptin Sales by Players (2023, 2024 & 2025)
5 Global Gemigliptin Market Size by Region
5.1 Global Gemigliptin Market Size by Region: 2021 VS 2025 VS 2031
5.2 Global Gemigliptin Market Size in Volume by Region (2025-2031)
5.2.1 Global Gemigliptin Sales in Volume by Region: 2021-2025
5.2.2 Global Gemigliptin Sales in Volume Forecast by Region (2025-2031)
5.3 Global Gemigliptin Market Size in Value by Region (2025-2031)
5.3.1 Global Gemigliptin Sales in Value by Region: 2021-2025
5.3.2 Global Gemigliptin Sales in Value by Region: 2025-2031
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Gemigliptin Market Size YoY Growth 2025-2031
6.1.2 North America Gemigliptin Market Facts & Figures by Country (2021, 2025 & 2031)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Gemigliptin Market Size YoY Growth 2025-2031
6.2.2 Asia-Pacific Gemigliptin Market Facts & Figures by Region (2021, 2025 & 2031)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Gemigliptin Market Size YoY Growth 2025-2031
6.3.2 Europe Gemigliptin Market Facts & Figures by Country (2021, 2025 & 2031)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Gemigliptin Market Size YoY Growth 2025-2031
6.4.2 Latin America Gemigliptin Market Facts & Figures by Country (2021, 2025 & 2031)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Gemigliptin Market Size YoY Growth 2025-2031
6.5.2 Middle East and Africa Gemigliptin Market Facts & Figures by Country (2021, 2025 & 2031)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Corporation Information
7.1.2 Sanofi Description and Business Overview
7.1.3 Sanofi Gemigliptin Sales, Revenue and Gross Margin (2021-2025)
7.1.4 Sanofi Gemigliptin Products Offered
7.1.5 Sanofi Recent Development
7.2 LG Chem
7.2.1 LG Chem Corporation Information
7.2.2 LG Chem Description and Business Overview
7.2.3 LG Chem Gemigliptin Sales, Revenue and Gross Margin (2021-2025)
7.2.4 LG Chem Gemigliptin Products Offered
7.2.5 LG Chem Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Gemigliptin Industry Chain Analysis
8.2 Gemigliptin Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Gemigliptin Distributors
8.3 Gemigliptin Production Mode & Process
8.4 Gemigliptin Sales and Marketing
8.4.1 Gemigliptin Sales Channels
8.4.2 Gemigliptin Distributors
8.5 Gemigliptin Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

List of Tables
Table 1. Gemigliptin CAGR in Value, United States VS Global, 2021 VS 2025 VS 2031
Table 2. Gemigliptin Market Trends
Table 3. Gemigliptin Market Drivers
Table 4. Gemigliptin Market Challenges
Table 5. Gemigliptin Market Restraints
Table 6. Global Gemigliptin Sales by Type: 2021 VS 2025 VS 2031 (US$ Million)
Table 7. United States Gemigliptin Sales by Type: 2021 VS 2025 VS 2031 (US$ Million)
Table 8. Global Gemigliptin Sales by Application: 2021 VS 2025 VS 2031 (US$ Million)
Table 9. United States Gemigliptin Sales by Application: 2021 VS 2025 VS 2031 (US$ Million)
Table 10. Top Gemigliptin Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Gemigliptin Revenue by Manufacturer, (US$ Million), 2021-2025
Table 12. Global Gemigliptin Revenue Share by Manufacturer, 2021-2025
Table 13. Global Gemigliptin Sales by Manufacturer, (K Units), 2021-2025
Table 14. Global Gemigliptin Sales Share by Manufacturer, 2021-2025
Table 15. Global Gemigliptin Price by Manufacturer (2021-2025) & (US$/Unit)
Table 16. Global Gemigliptin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Gemigliptin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gemigliptin as of 2021)
Table 18. Top Players of Gemigliptin in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Gemigliptin Product Type
Table 20. Date of International Manufacturers Enter into Gemigliptin Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Gemigliptin Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Gemigliptin Revenue by Players, (US$ Million), 2023, 2024 & 2025
Table 24. United States Gemigliptin Revenue Share by Players, 2023, 2024 & 2025
Table 25. United States Gemigliptin Sales by Players, (K Units), 2023, 2024 & 2025
Table 26. United States Gemigliptin Sales Share by Players, 2023, 2024 & 2025
Table 27. Global Gemigliptin Market Size by Region (US$ Million): 2021 VS 2025 VS 2031
Table 28. Global Gemigliptin Sales in Volume by Region (2021-2025) & (K Units)
Table 29. Global Gemigliptin Sales in Volume Forecast by Region (2025-2031) & (K Units)
Table 30. Global Gemigliptin Sales in Value by Region (2021-2025) & (US$ Million)
Table 31. Global Gemigliptin Sales in Value Forecast by Region (2025-2031) & (US$ Million)
Table 32. North America Gemigliptin Sales in Volume by Country (2025-2031) & (K Units)
Table 33. North America Gemigliptin Sales in Value by Country (2025-2031) & (US$ Million)
Table 34. Asia Pacific Gemigliptin Sales in Volume by Region (2025-2031) & (K Units)
Table 35. Asia Pacific Gemigliptin Sales in Value by Region (2025-2031) & (US$ Million)
Table 36. Europe Gemigliptin Sales in Volume by Country (2025-2031) & (K Units)
Table 37. Europe Gemigliptin Sales in Value by Country (2025-2031) & (US$ Million)
Table 38. Latin America Gemigliptin Sales in Volume by Country (2025-2031) & (K Units)
Table 39. Latin Americaa Gemigliptin Sales in Value by Country (2025-2031) & (US$ Million)
Table 40. Middle East and Africa Gemigliptin Sales in Volume by Country (2025-2031) & (K Units)
Table 41. Middle East and Africa Gemigliptin Sales in Value by Country (2025-2031) & (US$ Million)
Table 42. Sanofi Corporation Information
Table 43. Sanofi Description and Business Overview
Table 44. Sanofi Gemigliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 45. Sanofi Gemigliptin Product
Table 46. Sanofi Recent Development
Table 47. LG Chem Corporation Information
Table 48. LG Chem Description and Business Overview
Table 49. LG Chem Gemigliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 50. LG Chem Product
Table 51. LG Chem Recent Development
Table 52. Key Raw Materials Lists
Table 53. Raw Materials Key Suppliers Lists
Table 54. Gemigliptin Customers List
Table 55. Gemigliptin Distributors List
Table 56. Research Programs/Design for This Report
Table 57. Key Data Information from Secondary Sources
Table 58. Key Data Information from Primary Sources
List of Figures
Figure 1. Gemigliptin Product Picture
Figure 2. Global Gemigliptin Revenue, (US$ Million), 2021 VS 2025 VS 2031
Figure 3. Global Gemigliptin Market Size 2025-2031 (US$ Million)
Figure 4. Global Gemigliptin Sales 2025-2031 (K Units)
Figure 5. United States Gemigliptin Revenue, (US$ Million), 2021 VS 2025 VS 2031
Figure 6. United States Gemigliptin Market Size 2025-2031 (US$ Million)
Figure 7. United States Gemigliptin Sales 2025-2031 (K Units)
Figure 8. United States Gemigliptin Market Share in Global, in Value (US$ Million) 2025-2031
Figure 9. United States Gemigliptin Market Share in Global, in Volume (K Units) 2025-2031
Figure 10. Gemigliptin Report Years Considered
Figure 11. Product Picture of For Type 2 Diabetes
Figure 12. Product Picture of Others
Figure 13. Global Gemigliptin Market Share by Type in 2025 & 2031
Figure 14. Global Gemigliptin Sales in Value by Type (2025-2031) & (US$ Million)
Figure 15. Global Gemigliptin Sales Market Share in Value by Type (2025-2031)
Figure 16. Global Gemigliptin Sales by Type (2025-2031) & (K Units)
Figure 17. Global Gemigliptin Sales Market Share in Volume by Type (2025-2031)
Figure 18. Global Gemigliptin Price by Type (2025-2031) & (US$/Unit)
Figure 19. United States Gemigliptin Market Share by Type in 2025 & 2031
Figure 20. United States Gemigliptin Sales in Value by Type (2025-2031) & (US$ Million)
Figure 21. United States Gemigliptin Sales Market Share in Value by Type (2025-2031)
Figure 22. United States Gemigliptin Sales by Type (2025-2031) & (K Units)
Figure 23. United States Gemigliptin Sales Market Share in Volume by Type (2025-2031)
Figure 24. United States Gemigliptin Price by Type (2025-2031) & (US$/Unit)
Figure 25. Product Picture of Clinical Use
Figure 26. Product Picture of Hospital Use
Figure 27. Global Gemigliptin Market Share by Application in 2025 & 2031
Figure 28. Global Gemigliptin Sales in Value by Application (2025-2031) & (US$ Million)
Figure 29. Global Gemigliptin Sales Market Share in Value by Application (2025-2031)
Figure 30. Global Gemigliptin Sales by Application (2025-2031) & (K Units)
Figure 31. Global Gemigliptin Sales Market Share in Volume by Application (2025-2031)
Figure 32. Global Gemigliptin Price by Application (2025-2031) & (US$/Unit)
Figure 33. United States Gemigliptin Market Share by Application in 2025 & 2031
Figure 34. United States Gemigliptin Sales in Value by Application (2025-2031) & (US$ Million)
Figure 35. United States Gemigliptin Sales Market Share in Value by Application (2025-2031)
Figure 36. United States Gemigliptin Sales by Application (2025-2031) & (K Units)
Figure 37. United States Gemigliptin Sales Market Share in Volume by Application (2025-2031)
Figure 38. United States Gemigliptin Price by Application (2025-2031) & (US$/Unit)
Figure 39. North America Gemigliptin Sales in Volume Growth Rate 2025-2031 (K Units)
Figure 40. North America Gemigliptin Sales in Value Growth Rate 2025-2031 (US$ Million)
Figure 41. United States Gemigliptin Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 42. Canada Gemigliptin Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 43. Europe Gemigliptin Sales in Volume Growth Rate 2025-2031 (K Units)
Figure 44. Europe Gemigliptin Sales in Value Growth Rate 2025-2031 (US$ Million)
Figure 45. Germany Gemigliptin Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 46. France Gemigliptin Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 47. U.K. Gemigliptin Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 48. Italy Gemigliptin Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 49. Russia Gemigliptin Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 50. Asia-Pacific Gemigliptin Sales in Volume Growth Rate 2025-2031 (K Units)
Figure 51. Asia-Pacific Gemigliptin Sales in Value Growth Rate 2025-2031 (US$ Million)
Figure 52. China Gemigliptin Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 53. Japan Gemigliptin Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 54. South Korea Gemigliptin Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 55. India Gemigliptin Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 56. Australia Gemigliptin Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 57. China Taiwan Gemigliptin Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 58. Indonesia Gemigliptin Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 59. Thailand Gemigliptin Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 60. Malaysia Gemigliptin Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 61. Latin America Gemigliptin Sales in Volume Growth Rate 2025-2031 (K Units)
Figure 62. Latin America Gemigliptin Sales in Value Growth Rate 2025-2031 (US$ Million)
Figure 63. Mexico Gemigliptin Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 64. Brazil Gemigliptin Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 65. Argentina Gemigliptin Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 66. Middle East & Africa Gemigliptin Sales in Volume Growth Rate 2025-2031 (K Units)
Figure 67. Middle East & Africa Gemigliptin Sales in Value Growth Rate 2025-2031 (US$ Million)
Figure 68. Turkey Gemigliptin Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 69. Saudi Arabia Gemigliptin Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 70. UAE Gemigliptin Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 71. Gemigliptin Value Chain
Figure 72. Gemigliptin Production Process
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:

Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.

Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.

Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.

Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.

Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.